The Efficacy and Safety of Different Doses of SY-009 in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT05426018 · UNKNOWN
Trial details
- NCT number
- NCT05426018
- Sponsor
- Suzhou Yabao Pharmaceutical R&D Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2023-06-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.